Virtus ETF Advisers LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$226,000
+96.5%
6,118
+0.8%
0.09%
+109.3%
Q2 2022$115,000
-50.0%
6,068
-28.7%
0.04%
-58.3%
Q1 2022$230,000
+13.3%
8,516
-5.5%
0.10%
+33.8%
Q4 2021$203,000
+15.3%
9,015
+34.5%
0.08%0.0%
Q3 2021$176,000
-22.1%
6,703
-5.0%
0.08%
-17.2%
Q2 2021$226,000
-28.3%
7,056
-21.1%
0.09%
-30.1%
Q1 2021$315,000
+11.7%
8,947
+1.9%
0.13%
+13.7%
Q4 2020$282,000
+14.2%
8,783
+33.8%
0.12%
-10.0%
Q3 2020$247,000
-26.0%
6,564
-12.0%
0.13%
-17.7%
Q2 2020$334,0007,4630.16%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders